|
Other links at Biotechnology and Pharmaceuticals > Pharmaceuticals > Biopharmaceuticals > Research and Development |
| 1. |
Curis, Inc
|
|
|
Developing small molecule and peptide drugs in regulatory signaling and regenerative pathways. Introduces technical background, product pipeline, collaborations, investment data and careers headquartered from Cambridge, Massachusetts. (Nasdaq: CVGP)
|
| 2. |
Archemix Corp.
|
|
|
Company developing therapeutics of aptamers, for the prevention and treatment of chronic and acute disease. Includes overview of technology and commercial potential, careers and contacts in Cambridge, Massachusetts.
|
| 3. |
Novacta Biosystems Ltd.
|
|
|
Drug discovery and development company using pathway engineering and chemistry to optimise the activity of natural products for the treatment of infectious diseases. Introduces biotransformation technology, lead compounds, key personnel in Hatfield, England.
|
| 4. |
Xoma
|
|
|
Development and manufacture of recombinant proteins and peptides, in partnership with big pharmas. Includes licensing of technology derived from the host-defense protein BPI, monoclonal antibodies to treat chemotherapy-induced thrombocytopenia, and to target cancer. Based in Berkeley, California.
|
| 5. |
Nymox Pharmaceutical Corp.
|
|
|
Researches and develops neurological diagnostics and pharmaceuticals for the aging population with emphasis on Alzheimer's disease. Profile of company with bases in Maywood, New Jersey and Saint Laurent, Quebec. (Nasdaq: NYMX)
|
|
|
Add to My Favorite
Refer it to Friend
Report Broken Link
